The Effects of Resveratrol in the Treatment of Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Resveratrol, also known as 3,5,4′-trihydroxystilbene, is a natural polyphenol that occurs as a phytoalexin. It is produced by plant sources such as grapes, apples, blueberries, plums, peanuts, and other oilseeds. This compound has a variety of effects on human health and diseases. This review summarizes the mounting evidence that resveratrol is helpful in treating metabolic syndrome and related disorders. Resveratrol can be provided either early as a reprogramming agent or later as part of treatment. A few of the main mechanisms underlying the beneficial effects of resveratrol on metabolic syndrome are outlined. This review also discusses the potential of resveratrol derivatives as a complementary or alternative medicine. In conclusion, resveratrol could be a useful regimen for the prevention and treatment of metabolic syndrome and its related conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 1×
“This decrease in insulin was not accompanied by alterations in fasting glucose levels and was accompanied by improved insulin sensitivity [89].”
BackgroundEffect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · cited 5×
“Developmental programming, also known as DOHaD [37], refers to exposure during prenatal or early postnatal development that may cause permanent changes in an individual’s physiology and metabolism that predispose them to non-communicable diseases, such as Alzheimer’s, asthma, Figure 2.”
BackgroundInfluentialRelation between body mass index and cognitive function in healthy middle-aged men and women
Cournot, M., Marquié, J. C., Ansiau, D., Martinaud, C., Fonds, H., Ferrières, J., & Ruidavets, J. B. (2006) · Neurology · doi:10.1212/01.wnl.0000238082.13860.50 · Cited by 517
The molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477 · cited 1×
“AMPK has emerged as a key nutrient sensor, with the ability to regulate whole-body metabolism [24], coordinating many metabolic reactions [25] to maintain metabolic homeostasis and induce the inflammatory response [26].”
BackgroundTargeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Cantó, C., & Auwerx, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003905 · Cited by 433
Gunstad, J., Lhotsky, A., Wendell, C. R., Ferrucci, L., & Zonderman, A. B. (2010) · Neuroepidemiology · doi:10.1159/000297742 · Cited by 369 · cited 2×
“People with metabolic syndrome are more likely to experience cognitive dysfunction as obesity is an independent risk factor for the development of cognitive decline in both the middle-aged and elderly [48,54].”
BackgroundQiao, Y., Sun, J., Xia, S., Tang, X., Shi, Y., & Le, G. (2014) · Food & Function · doi:10.1039/c3fo60630a · Cited by 367 · cited 1×
“Resveratrol might alter gut microbiome, affect the gut-brain axis, and have a role in brain disorders [15,30,52].”
BackgroundMéndez-del Villar, M., González-Ortiz, M., Martínez-Abundis, E., Pérez-Rubio, K. G., & Lizárraga-Valdez, R. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0082 · Cited by 246 · cited 1×
“A randomized, double-blind, placebo-controlled clinical trial in 24 patients with diagnoses of metabolic syndrome showed that resveratrol significantly decreases weight, Body Mass Index (BMI), fat mass, waist circumference, area under curve of insulin, and total insulin secretion [44].”
Resveratrol: Anti-Obesity Mechanisms of Action
Aguirre, L., Fernández-Quintela, A., Arias, N., & Portillo, M. (2014) · Molecules · doi:10.3390/molecules191118632 · Cited by 205 · cited 1×
“Resveratrol treatment has been demonstrated to decrease lipogenesis and increase lipolysis, thus having an anti-obesity effect [74].”
BackgroundResveratrol regulates human adipocyte number and function in a Sirt1-dependent manner
Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K.-M., Fulda, S., & Wabitsch, M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28435 · Cited by 195 · cited 1×
“An in vitro study also showed that resveratrol treatment inhibited preadipocyte proliferation, adipogenic differentiation and inflammatory cytokines production in a Sirt1-dependent manner [77].”
Background
Cited by
Mitochondrial dysfunction in metabolic syndrome
Prasun, P. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165838 · Cited by 364
Scaglione, S., Di Chiara, T., Daidone, M., & Tuttolomondo, A. (2025) · Nutrients · doi:10.3390/nu17020358 · Cited by 92
“Ultimately, the polyphenols characteristic of the Mediterranean diet alleviate inflammation, oxidative stress, insulin resistance, lipid oxidation, body weight issues, blood pressure, and endothelial dysfunction, thereby addressing key risk factors associated with metabolic syndrome [62].”
Batista-Jorge, G. C., Barcala-Jorge, A. S., Silveira, M. F., Lelis, D. F., Andrade, J. M. O., de Paula, A. M. B., Guimarães, A. L. S., & Santos, S. H. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117962 · Cited by 55
Role of Drug Delivery System in Improving the Bioavailability of Resveratrol
Saleem, Z., Rehman, K., & Hamid Akash, M. S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220705113514 · Cited by 34
Metadata
- Authors
- Hou, C.-Y., Tain, Y.-L., Yu, H.-R., & Huang, L.-T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-01-28
- Volume
- 20
- Issue
- 3
- Pages
- 535
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2911285956
- Cited by
- 136
- References
- 13
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of Resveratrol in the Treatment of Metabolic Syndrome. https://app.cochat.ai/papers/10.3390/ijms20030535
- The paper
- Hou, C.-Y., Tain, Y.-L., Yu, H.-R., & Huang, L.-T. (2019). The Effects of Resveratrol in the Treatment of Metabolic Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms20030535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.